razoxane has been researched along with 3,4-dihydroxybenzohydroxamic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tryka, AF | 1 |
Campbell, ED; Carter, WH; Stablein, DM; Wampler, GL | 1 |
2 other study(ies) available for razoxane and 3,4-dihydroxybenzohydroxamic acid
Article | Year |
---|---|
ICRF 187 and polyhydroxyphenyl derivatives fail to protect against bleomycin induced lung injury.
Topics: 2,4-Dichlorophenoxyacetic Acid; Animals; Bleomycin; Cricetinae; Free Radicals; Hydroxamic Acids; Iron Chelating Agents; Lung; Lung Diseases; Male; Mesocricetus; Oxygen; Piperazines; Pulmonary Fibrosis; Razoxane | 1989 |
Drug activity and therapeutic synergism in cancer treatment.
Topics: Animals; Antineoplastic Agents; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Fluorouracil; Humans; Hydroxamic Acids; Lung Neoplasms; Male; Melanoma; Mice; Mitomycin; Mitomycins; Neoplasms; Neoplasms, Experimental; Rats; Razoxane; Teniposide | 1982 |